Nucleoside Metabolic Inhibitor
56 drugs across 28 manufacturers|54 Generic,2 Brand
The Nucleoside Metabolic Inhibitor class contains 56 NDCs from 28 manufacturers (54 generic, 2 brand), at an average NADAC of $3.32 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
56
54G / 2B
Manufacturers
28
Avg $3.3182/unit
Avg 7d Change
-2.36%
Across 27 drugs with changes
7d Activity
of 56 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Nucleoside Metabolic Inhibitor class?
The Nucleoside Metabolic Inhibitor class contains 56 NDCs from 28 manufacturers — 54 generic and 2 brand products.
What is the average price of Nucleoside Metabolic Inhibitor drugs?
The average NADAC for the Nucleoside Metabolic Inhibitor class is $3.3182 per unit across 56 NDCs.
Is generic cheaper than brand in the Nucleoside Metabolic Inhibitor class?
The average generic NADAC in this class is $3.2955 per unit, versus $3.9300 for brand — generic is about 16% cheaper on average.
Which manufacturers make Nucleoside Metabolic Inhibitor drugs?
28 manufacturers make drugs in the Nucleoside Metabolic Inhibitor class. Ranked by number of NDCs, the largest are NorthStar Rx LLC (5), BluePoint Laboratories (4), Taro Pharmaceuticals U.S.A. Inc. (3), Dr. Reddy's Laboratories Inc. (3), Accord Healthcare Inc. (3).
How has Nucleoside Metabolic Inhibitor pricing changed recently?
Over the past 7 days, 7 NDCs in this class rose and 20 fell, with a class-wide average change of -2.4%.
Manufacturer Breakdown
28 manufacturers producing drugs in this therapeutic class(5 pricing outliers)
and 16 more manufacturers